non-invasive sagging skin treatment glp-1 no downtime In early 2025, the AAFPRS reported that "Ozempic face," the skin, wrinkles and hollowed cheeks associated with GLP-1-related weight loss, had led to an increase in fat grafting procedures and other rich microalgae enhance the performance of the formula while helping to protect and nourish the skin’s barrier—revealing a firmer Ozempic Face Treatment in NYC

Beyond pharmacokinetics, nanotoxicology and immunogenicity remain major translational bottlenecks

Very sweet foods, large portions, and eating quickly also make it worse

GLP-1 brands have been steadily expanding their reach through new indications, with Ozempic and Wegovy adding cardiovascular risk reduction in 2020 and 2024 respectively, and Zepbound adding obstructive sleep apnea in 2024

Sagging is different

In a statement, Ro said, "We are working to ensure patients have access to the most effective medications available and will continue to follow all applicable FDA rules and guidelines." The supply update "starts the clock on having unfettered market access to the patented drug" for companies like Hims & Hers and the broader compounding GLP-1 space, analysts at Leerink Partners wrote in a note to clients Friday morning